1. Home
  2. CGEM vs USNA Comparison

CGEM vs USNA Comparison

Compare CGEM & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • USNA
  • Stock Information
  • Founded
  • CGEM 2016
  • USNA 1992
  • Country
  • CGEM United States
  • USNA United States
  • Employees
  • CGEM N/A
  • USNA N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • CGEM Health Care
  • USNA Health Care
  • Exchange
  • CGEM Nasdaq
  • USNA Nasdaq
  • Market Cap
  • CGEM 482.7M
  • USNA 565.5M
  • IPO Year
  • CGEM 2021
  • USNA 1996
  • Fundamental
  • Price
  • CGEM $6.45
  • USNA $30.45
  • Analyst Decision
  • CGEM Strong Buy
  • USNA Hold
  • Analyst Count
  • CGEM 8
  • USNA 1
  • Target Price
  • CGEM $27.25
  • USNA $36.00
  • AVG Volume (30 Days)
  • CGEM 525.8K
  • USNA 103.4K
  • Earning Date
  • CGEM 11-06-2025
  • USNA 10-21-2025
  • Dividend Yield
  • CGEM N/A
  • USNA N/A
  • EPS Growth
  • CGEM N/A
  • USNA N/A
  • EPS
  • CGEM N/A
  • USNA 1.80
  • Revenue
  • CGEM N/A
  • USNA $899,221,000.00
  • Revenue This Year
  • CGEM N/A
  • USNA $13.94
  • Revenue Next Year
  • CGEM N/A
  • USNA $7.95
  • P/E Ratio
  • CGEM N/A
  • USNA $16.78
  • Revenue Growth
  • CGEM N/A
  • USNA 2.75
  • 52 Week Low
  • CGEM $6.44
  • USNA $23.10
  • 52 Week High
  • CGEM $18.62
  • USNA $41.84
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 36.01
  • USNA 45.95
  • Support Level
  • CGEM $6.44
  • USNA $29.67
  • Resistance Level
  • CGEM $7.82
  • USNA $30.93
  • Average True Range (ATR)
  • CGEM 0.43
  • USNA 0.69
  • MACD
  • CGEM -0.11
  • USNA -0.15
  • Stochastic Oscillator
  • CGEM 4.55
  • USNA 30.53

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Share on Social Networks: